Annual Total Debt:
$1.34B-$53.74M(-3.85%)Summary
- As of today (May 29, 2025), SRPT annual total debt is $1.34 billion, with the most recent change of -$53.74 million (-3.85%) on December 31, 2024.
- During the last 3 years, SRPT annual total debt has risen by +$189.63 million (+16.44%).
- SRPT annual total debt is now -16.96% below its all-time high of $1.62 billion, reached on December 31, 2022.
Performance
SRPT Total debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Total Debt:
$1.34B+$679.00K(+0.05%)Summary
- As of today (May 29, 2025), SRPT quarterly total debt is $1.34 billion, with the most recent change of +$679.00 thousand (+0.05%) on March 1, 2025.
- Over the past year, SRPT quarterly total debt has dropped by -$35.60 million (-2.58%).
- SRPT quarterly total debt is now -16.92% below its all-time high of $1.62 billion, reached on December 31, 2022.
Performance
SRPT Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total debt Formula
Total Debt = Short Term Debt + Long Term Debt
SRPT Total debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.9% | -2.6% |
| 3 y3 years | +16.4% | +18.1% |
| 5 y5 years | +84.1% | +78.4% |
SRPT Total debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -17.0% | +16.4% | -16.9% | +18.1% |
| 5 y | 5-year | -17.0% | +84.1% | -16.9% | +78.4% |
| alltime | all time | -17.0% | >+9999.0% | -16.9% | >+9999.0% |
SRPT Total debt History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $1.34B(+0.1%) |
| Dec 2024 | $1.34B(-3.8%) | $1.34B(-3.9%) |
| Sep 2024 | - | $1.40B(+2.0%) |
| Jun 2024 | - | $1.37B(-0.7%) |
| Mar 2024 | - | $1.38B(-1.2%) |
| Dec 2023 | $1.40B(-13.6%) | $1.40B(+1.8%) |
| Sep 2023 | - | $1.37B(+0.5%) |
| Jun 2023 | - | $1.36B(+5.9%) |
| Mar 2023 | - | $1.29B(-20.4%) |
| Dec 2022 | $1.62B(+40.2%) | $1.62B(+2.5%) |
| Sep 2022 | - | $1.58B(+38.4%) |
| Jun 2022 | - | $1.14B(+0.2%) |
| Mar 2022 | - | $1.14B(-1.4%) |
| Dec 2021 | $1.15B(+7.5%) | $1.15B(-0.4%) |
| Sep 2021 | - | $1.16B(+0.0%) |
| Jun 2021 | - | $1.16B(+0.6%) |
| Mar 2021 | - | $1.15B(+7.4%) |
| Dec 2020 | $1.07B(+47.0%) | $1.07B(+39.6%) |
| Sep 2020 | - | $768.70M(+0.3%) |
| Jun 2020 | - | $766.56M(+1.8%) |
| Mar 2020 | - | $753.22M(+3.2%) |
| Dec 2019 | $729.62M(+73.5%) | $729.62M(+50.1%) |
| Sep 2019 | - | $486.16M(+1.0%) |
| Jun 2019 | - | $481.25M(+0.7%) |
| Mar 2019 | - | $477.92M(+13.6%) |
| Dec 2018 | $420.55M(-2.4%) | $420.55M(+1.2%) |
| Sep 2018 | - | $415.45M(-5.5%) |
| Jun 2018 | - | $439.44M(+2.0%) |
| Mar 2018 | - | $430.81M(-0.1%) |
| Dec 2017 | $431.05M(+2569.0%) | $431.05M(+1278.0%) |
| Sep 2017 | - | $31.28M(+178.9%) |
| Jun 2017 | - | $11.22M(-18.1%) |
| Mar 2017 | - | $13.69M(-15.2%) |
| Dec 2016 | $16.15M(-31.0%) | $16.15M(-13.2%) |
| Sep 2016 | - | $18.60M(-8.0%) |
| Jun 2016 | - | $20.22M(-3.6%) |
| Mar 2016 | - | $20.98M(-10.3%) |
| Dec 2015 | $23.40M(+269.8%) | $23.40M(+0.5%) |
| Sep 2015 | - | $23.29M(-9.3%) |
| Jun 2015 | - | $25.66M(+302.2%) |
| Mar 2015 | - | $6.38M(+0.8%) |
| Dec 2014 | $6.33M(+279.4%) | $6.33M(+0.8%) |
| Sep 2014 | - | $6.28M(+287.1%) |
| Jun 2014 | - | $1.62M(-1.5%) |
| Mar 2014 | - | $1.65M(-1.4%) |
| Dec 2013 | $1.67M(-5.1%) | $1.67M(-1.3%) |
| Sep 2013 | - | $1.69M(-1.3%) |
| Jun 2013 | - | $1.71M(-1.3%) |
| Mar 2013 | - | $1.74M(-1.3%) |
| Dec 2012 | $1.76M(-4.6%) | $1.76M(-1.2%) |
| Sep 2012 | - | $1.78M(-1.2%) |
| Jun 2012 | - | $1.80M(-1.2%) |
| Mar 2012 | - | $1.82M(-1.1%) |
| Dec 2011 | $1.84M(-4.2%) | $1.84M(-1.1%) |
| Sep 2011 | - | $1.86M(-1.1%) |
| Jun 2011 | - | $1.88M(-1.1%) |
| Mar 2011 | - | $1.90M(-1.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2010 | $1.92M(-3.9%) | $1.92M(-1.0%) |
| Sep 2010 | - | $1.94M(-1.0%) |
| Jun 2010 | - | $1.96M(-36.5%) |
| Mar 2010 | - | $3.09M(+54.4%) |
| Dec 2009 | $2.00M(-22.7%) | $2.00M(-1.2%) |
| Sep 2009 | - | $2.03M(-22.6%) |
| Jun 2009 | - | $2.62M(+1.2%) |
| Mar 2009 | - | $2.59M(-0.2%) |
| Dec 2008 | $2.59M(+20.9%) | $2.59M(+24.0%) |
| Sep 2008 | - | $2.09M(-0.8%) |
| Jun 2008 | - | $2.11M(-0.8%) |
| Mar 2008 | - | $2.12M(-0.8%) |
| Dec 2007 | $2.14M(>+9900.0%) | $2.14M(-0.8%) |
| Sep 2007 | - | $2.16M(-0.8%) |
| Jun 2007 | - | $2.18M(>+9900.0%) |
| Mar 2007 | - | $0.00(0.0%) |
| Dec 2006 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2006 | - | $0.00(0.0%) |
| Jun 2006 | - | $0.00(0.0%) |
| Mar 2006 | - | $0.00(0.0%) |
| Dec 2005 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2005 | - | $0.00(0.0%) |
| Jun 2005 | - | $0.00(0.0%) |
| Mar 2005 | - | $0.00(0.0%) |
| Dec 2004 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2004 | - | $0.00(0.0%) |
| Jun 2004 | - | $0.00(0.0%) |
| Mar 2004 | - | $0.00(0.0%) |
| Dec 2003 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2003 | - | $0.00(0.0%) |
| Jun 2003 | - | $0.00(0.0%) |
| Mar 2003 | - | $0.00(0.0%) |
| Dec 2002 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2002 | - | $0.00(0.0%) |
| Jun 2002 | - | $0.00(0.0%) |
| Mar 2002 | - | $0.00(0.0%) |
| Dec 2001 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2001 | - | $0.00(0.0%) |
| Jun 2001 | - | $0.00(0.0%) |
| Mar 2001 | - | $0.00(0.0%) |
| Dec 2000 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2000 | - | $0.00(0.0%) |
| Jun 2000 | - | $0.00(0.0%) |
| Mar 2000 | - | $0.00(0.0%) |
| Dec 1999 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 1999 | - | $0.00(0.0%) |
| Jun 1999 | - | $0.00(0.0%) |
| Mar 1999 | - | $0.00(0.0%) |
| Dec 1998 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 1998 | - | $0.00(0.0%) |
| Jun 1998 | - | $0.00(0.0%) |
| Mar 1998 | - | $0.00(0.0%) |
| Dec 1997 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 1997 | - | $0.00(0.0%) |
| Jun 1997 | - | $0.00(0.0%) |
| Mar 1997 | - | $0.00 |
| Dec 1996 | $0.00 | - |
FAQ
- What is Sarepta Therapeutics annual total debt?
- What is the all time high annual total debt for Sarepta Therapeutics?
- What is Sarepta Therapeutics annual total debt year-on-year change?
- What is Sarepta Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly total debt year-on-year change?
What is Sarepta Therapeutics annual total debt?
The current annual total debt of SRPT is $1.34B
What is the all time high annual total debt for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual total debt is $1.62B
What is Sarepta Therapeutics annual total debt year-on-year change?
Over the past year, SRPT annual total debt has changed by -$53.74M (-3.85%)
What is Sarepta Therapeutics quarterly total debt?
The current quarterly total debt of SRPT is $1.34B
What is the all time high quarterly total debt for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly total debt is $1.62B
What is Sarepta Therapeutics quarterly total debt year-on-year change?
Over the past year, SRPT quarterly total debt has changed by -$35.60M (-2.58%)